Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ducoulombier, Frédéric
17  Ergebnisse:
Personensuche X
?
1

Accounting for cross-factor interactions in multifactor por..:

, In: The journal of portfolio management
Amenc, Noël ; Ducoulombier, Frédéric ; Esakia, Mikheil ; Goltz, Felix.. (2017)  5 - p. 99-114
Exemplare:  Zentrale:E02 z swl 179.5 je/837; Zentrale:Magazin Zs fc 8837
 
?
2

Diversified or concentrated factor tilts?:

, In: The journal of portfolio management
Amenc, Noël ; Ducoulombier, Frédéric ; Goltz, Felix ; Lodh, Ashish.. (2016)  2 - p. 64-76
Exemplare:  Zentrale:E02 z swl 179.5 je/837; Zentrale:Magazin Zs fc 8837
 
?
3

Improved Metastatic-Free Survival after Systematic Re-Excis..:

Gouin, Francois ; Michot, Audrey ; Jafari, Mehrdad...
Cancers.  16 (2024)  7 - p. 1365 , 2024
Link: https://doi.org/10.3390/..
 
?
4

Trastuzumab deruxtecan in metastatic breast cancer with var..:

Mosele, Fernanda ; Deluche, Elise ; Lusque, Amelie...
Nature Medicine.  29 (2023)  8 - p. 2110-2120 , 2023
Link: https://doi.org/10.1038/..
 
?
5

Genome profiling is an efficient tool to avoid the STUMP cl..:

Croce, Sabrina ; Ducoulombier, Agnès ; Ribeiro, Agnès...
Modern Pathology.  31 (2018)  5 - p. 816-828 , 2018
Link: https://doi.org/10.1038/..
 
?
6

Autoimmune thyroid disorders during anti-TNF alpha therapy:..:

Pascart, Tristan ; Ducoulombier, Vincent ; Roquette, Diane...
Joint Bone Spine.  81 (2014)  4 - p. 369-370 , 2014
Link: https://doi.org/10.1016/..
 
?
7

Anomalies thyroïdiennes auto-immunes au cours des traitemen..:

Pascart, Tristan ; Ducoulombier, Vincent ; Roquette, Diane...
Revue du Rhumatisme.  81 (2014)  4 - p. 347-349 , 2014
Link: https://doi.org/10.1016/..
 
?
8

A human IFNGR1 small deletion hotspot associated with domin..:

Jouanguy, Emmanuelle ; Lamhamedi-Cherradi, Salma ; Lammas, David...
Nature Genetics.  21 (1999)  4 - p. 370-378 , 1999
Link: https://doi.org/10.1038/..
 
?
9

Trastuzumab deruxtecan in metastatic breast cancer with var..:

Mosele, Fernanda ; Deluche, Elise ; Lusque, Amelie...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02478-2.  , 2023
Link: https://hal.science/hal-..
 
?
10

Trastuzumab deruxtecan in metastatic breast cancer with var..:

Mosele, Fernanda ; Deluche, Elise ; Lusque, Amelie...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02478-2.  , 2023
Link: https://hal.science/hal-..
 
?
11

Trastuzumab deruxtecan in metastatic breast cancer with var..:

Mosele, Fernanda ; Deluche, Elise ; Lusque, Amelie...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02478-2.  , 2023
Link: https://hal.science/hal-..
 
?
12

Trastuzumab deruxtecan in metastatic breast cancer with var..:

Mosele, Fernanda ; Deluche, Elise ; Lusque, Amelie...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02478-2.  , 2023
Link: https://hal.science/hal-..
 
?
13

Trastuzumab deruxtecan in metastatic breast cancer with var..:

Mosele, Fernanda ; Deluche, Elise ; Lusque, Amelie...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02478-2.  , 2023
Link: https://hal.science/hal-..
 
?
14

Trastuzumab deruxtecan in metastatic breast cancer with var..:

Mosele, Fernanda ; Deluche, Elise ; Lusque, Amelie...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02478-2.  , 2023
Link: https://hal.science/hal-..
 
?
15

Trastuzumab deruxtecan in metastatic breast cancer with var..:

Mosele, Fernanda ; Deluche, Elise ; Lusque, Amelie...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-023-02478-2.  , 2023
Link: https://hal.science/hal-..
 
1-15